Cargando…
mitoTev‐TALE: a monomeric DNA editing enzyme to reduce mutant mitochondrial DNA levels
Pathogenic mitochondrial DNA (mtDNA) mutations often co‐exist with wild‐type molecules (mtDNA heteroplasmy). Phenotypes manifest when the percentage of mutant mtDNA is high (70–90%). Previously, our laboratory showed that mitochondria‐targeted transcription activator‐like effector nucleases (mitoTAL...
Autores principales: | Pereira, Claudia V, Bacman, Sandra R, Arguello, Tania, Zekonyte, Ugne, Williams, Sion L, Edgell, David R, Moraes, Carlos T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127889/ https://www.ncbi.nlm.nih.gov/pubmed/30012581 http://dx.doi.org/10.15252/emmm.201708084 |
Ejemplares similares
-
Mitochondrial targeted meganuclease as a platform to eliminate mutant mtDNA in vivo
por: Zekonyte, Ugne, et al.
Publicado: (2021) -
Specific elimination of mutant mitochondrial genomes in patient–derived cells by mitoTALENs
por: Bacman, Sandra R., et al.
Publicado: (2013) -
Intra- and inter-molecular recombination of mitochondrial DNA after in vivo induction of multiple double-strand breaks
por: Bacman, Sandra R., et al.
Publicado: (2009) -
Organ-specific shifts in mtDNA heteroplasmy following systemic delivery of a mitochondria-targeted restriction endonuclease
por: Bacman, Sandra R., et al.
Publicado: (2010) -
Base editing in human cells with monomeric DddA-TALE fusion deaminases
por: Mok, Young Geun, et al.
Publicado: (2022)